Reshma Ramachandran
机构:Transparency International, Yale University, Yale New Haven Health System · ORCID:0000-0003-3845-3606
发表论文 136 篇 · 总被引 1426 次 · h-index 19
代表论文
- Postmarket Drug Safety−Related Actions Before and After the US Food and Drug Administration Amendments Act (2025 · JAMA Internal Medicine · 被引 5)
- Confirmatory evidence supporting single pivotal trial new drug approvals by the Food and Drug Administration, 2015 through 2023 (2025 · Clinical Trials · 被引 3)
- Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data (2025 · New England Journal of Medicine · 被引 2)
- Reforming the Prescription Drug User Fee Program (2025 · New England Journal of Medicine · 被引 2)
- Industry payments to US neurologists related to multiple sclerosis drugs and prescribing (2015–2019): a retrospective cohort study (2025 · BMJ Open · 被引 2)
- Internet Searches for Leucovorin, Folate, and Acetaminophen After a White House Autism Announcement (2026 · JAMA Network Open · 被引 1)